Dr. Saba Kamel Al-Hashimi, MD

Dr. Al-Hashimi practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Al-Hashimi's NPI, 1154687242, was assigned on April 3, 2012. Dr. Al-Hashimi graduated from VCU School of Medicine in 2012. Dr. Al-Hashimi holds California license A141976.

Dr. Al-Hashimi's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Al-Hashimi's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Al-Hashimi is also affiliated with Ronald Reagan UCLA Medical Center. Dmand AI also links Dr. Al-Hashimi to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Hashimi practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Al-Hashimi's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Al-Hashimi is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Al-Hashimi's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Al-Hashimi treats.

CMS data shows 1,647 Medicare services from Dr. Al-Hashimi across 15 procedure codes in 2024, for 585 Medicare patients. Medicare paid $185,964 for them.

CMS counts 585 Medicare patients who saw Dr. Al-Hashimi in 2024. The largest group is 75 to 84, with 252 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Al-Hashimi's median patient age at 69, with 56% women.

In 2024, Dr. Al-Hashimi wrote 1,899 Medicare Part D claims for 401 patients. 38% of them were for generic drugs. CMS names the drug for 1,777 of them, across 26 drugs with 11 or more claims each, at $256,747 in total drug cost. In 2023, CMS named 1,485 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Al-Hashimi for performance year 2024, reported as part of a group. Dr. Al-Hashimi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 124 procedures of cataract surgery by Dr. Al-Hashimi, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Al-Hashimi in 2019. Dr. Al-Hashimi's most frequent co-authors are Gavin G. Bahadur, MD, Richard S. Davidson, MD and Kendall E. Donaldson, MD.

Dmand AI links Dr. Al-Hashimi to 2 clinical trials. University of California, Los Angeles sponsors the most, 2.

CMS Open Payments shows 56 general payments to Dr. Al-Hashimi from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. GlaxoSmithKline, LLC. paid the most, $3,900.

Dr. Al-Hashimi graduated from VCU School of Medicine in 2012.

Dr. Al-Hashimi is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.